These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 3007045)
1. Advances in the biology of non-small cell lung cancer. Gazdar AF Chest; 1986 Apr; 89(4 Suppl):277S-283S. PubMed ID: 3007045 [TBL] [Abstract][Full Text] [Related]
2. Biological heterogeneity of small cell lung cancer. Carney DN; Gazdar AF; Nau M; Minna JD Semin Oncol; 1985 Sep; 12(3):289-303. PubMed ID: 2996148 [TBL] [Abstract][Full Text] [Related]
3. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts. Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935 [TBL] [Abstract][Full Text] [Related]
4. Nude mouse xenografts as in vivo models for lung carcinomas. Bepler G; Neumann K In Vivo; 1990; 4(5):309-15. PubMed ID: 1966790 [TBL] [Abstract][Full Text] [Related]
5. Integrated classification of lung tumors and cell lines by expression profiling. Virtanen C; Ishikawa Y; Honjoh D; Kimura M; Shimane M; Miyoshi T; Nomura H; Jones MH Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12357-62. PubMed ID: 12218176 [TBL] [Abstract][Full Text] [Related]
6. Growth of human bronchial carcinomas in nude mice. Mattern J; Jäger S; Sonka J; Wayss K; Volm M Br J Cancer; 1985 Feb; 51(2):195-200. PubMed ID: 2981540 [TBL] [Abstract][Full Text] [Related]
7. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties. Marini AM; Fridman R; Kanemoto T; Martin GR; Guo Y; Passaniti A J Natl Cancer Inst; 1992 Oct; 84(20):1582-7. PubMed ID: 1328660 [TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts. Arvelo F; Poupon MF; Le Chevalier T Anticancer Res; 1994; 14(5A):1893-901. PubMed ID: 7847823 [TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021 [TBL] [Abstract][Full Text] [Related]
10. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405 [TBL] [Abstract][Full Text] [Related]
11. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer. Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035 [TBL] [Abstract][Full Text] [Related]
12. Histologic type definition in clinical trials on advanced non-small cell lung cancer. Rossi G; Cavazza A J Thorac Oncol; 2011 Feb; 6(2):405. PubMed ID: 21252724 [No Abstract] [Full Text] [Related]
13. Transplantation of human tumors in nude mice. Shimosato Y; Kameya T; Nagai K; Hirohashi S; Koide T; Hayashi H; Nomura T J Natl Cancer Inst; 1976 Jun; 56(6):1251-60. PubMed ID: 186624 [TBL] [Abstract][Full Text] [Related]
14. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies. Varker KA; Phelps SH; King MM; Williams CL Int J Oncol; 2003 Mar; 22(3):671-81. PubMed ID: 12579323 [TBL] [Abstract][Full Text] [Related]
15. v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Mabry M; Nakagawa T; Nelkin BD; McDowell E; Gesell M; Eggleston JC; Casero RA; Baylin SB Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6523-7. PubMed ID: 2842776 [TBL] [Abstract][Full Text] [Related]
16. [Grading of lung cancer]. Bohle RM; Schnabel PA Pathologe; 2016 Jul; 37(4):314-9. PubMed ID: 27356985 [TBL] [Abstract][Full Text] [Related]
17. A light and electron microscopic study of lung cancers. Clinical implications. Chen HP; Berardi RS Int Surg; 1993; 78(2):124-6. PubMed ID: 8394841 [TBL] [Abstract][Full Text] [Related]
18. Development of three human small cell lung cancer models in nude mice. Fiebig HH; Neumann HA; Henss H; Koch H; Kaiser D; Arnold H Recent Results Cancer Res; 1985; 97():77-86. PubMed ID: 2986247 [TBL] [Abstract][Full Text] [Related]
19. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Fournié GJ; Courtin JP; Laval F; Chalé JJ; Pourrat JP; Pujazon MC; Lauque D; Carles P Cancer Lett; 1995 May; 91(2):221-7. PubMed ID: 7767913 [TBL] [Abstract][Full Text] [Related]
20. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents. Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]